XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
0.9959
+0.0001 (0.01%)
Aug 27, 2026, 10:57 AM EDT - Market open
XWELL Revenue
XWELL had revenue of $7.15M in the quarter ending June 30, 2026, a decrease of -7.08%. This brings the company's revenue in the last twelve months to $28.28M, down -7.58% year-over-year. In the year 2025, XWELL had annual revenue of $29.21M, down -13.83%.
Revenue (ttm)
$28.28M
Revenue Growth
-7.58%
P/S Ratio
0.30
Revenue / Employee
$101,007
Employees
280
Market Cap
8.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.21M | -4.69M | -13.83% |
| Dec 31, 2024 | 33.90M | 3.79M | 12.58% |
| Dec 31, 2023 | 30.11M | -25.83M | -46.18% |
| Dec 31, 2022 | 55.94M | -17.79M | -24.13% |
| Dec 31, 2021 | 73.73M | 65.34M | 779.30% |
| Dec 31, 2020 | 8.39M | -40.13M | -82.72% |
| Dec 31, 2019 | 48.52M | -1.58M | -3.15% |
| Dec 31, 2018 | 50.09M | 1.27M | 2.60% |
| Dec 31, 2017 | 48.82M | 36.84M | 307.33% |
| Dec 31, 2016 | 11.99M | -10.70M | -47.17% |
| Dec 31, 2015 | 22.69M | 21.26M | 1,492.07% |
| Dec 31, 2014 | 1.43M | 325.00K | 29.55% |
| Dec 31, 2013 | 1.10M | 1.00M | 1,000.00% |
| Dec 31, 2012 | 100.00K | -618.00K | -86.07% |
| Dec 31, 2011 | 718.00K | 507.00K | 240.28% |
| Dec 31, 2010 | 211.00K | 191.00K | 955.00% |
| Dec 31, 2009 | 20.00K | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MDxHealth | 114.02M |
| Burning Rock Biotech | 74.58M |
| Exagen | 71.12M |
| Precipio | 27.20M |
| bioAffinity Technologies | 5.90M |
| Insight Molecular Diagnostics | 1.67M |
| Quantum Cyber | 537.08K |
| iSpecimen | 466.30K |
XWEL News
- 12 days ago - XWELL Quarterly report: Q2 2026 - Filings
- 22 days ago - XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors - GlobeNewsWire
- 4 weeks ago - XWELL Proxy statement: Proxy filing - Filings
- 7 weeks ago - Xwell to divest XpresSpa, XpresTest businesses for $13M - TheFly
- 7 weeks ago - XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses - GlobeNewsWire
- 3 months ago - XWELL Quarterly report: Q1 2026 - Filings
- 5 months ago - Xwell reports FY25 revenue $29.2M - TheFly
- 5 months ago - XWELL Reports Fiscal 2025 Results - GlobeNewsWire